EFFECTS OF PERFLUORINATED COMPOUNDS (PFCs) ON METABOLIC TISSUES AND THE BENEFITS OF CALORIC RESTRICTION

作者: , Deanna Salter

DOI: 10.23860/DISS-SALTER-DEANNA-2015

关键词:

摘要: The CDC states that there has been a dramatic increase in obesity from 1990 to 2010. Type-II diabetes and prevalence are increasing worldwide. Often, concurrent, predispose individuals development of fatty liver disease, referred as Non-alcoholic disease (NAFLD). Perfluorooctane sulfonic acid (PFOS) perfluorooctanoic (PFOA) two commonly studied perfluorinated compounds (PFC’s) considered environmental toxicants have the potential elicit diabetic NAFLD phenotypes. This dissertation presents novel findings gaps within literature date. Traditionally, discussed regard with genetics, diet old age. Now, risk factors also need be chemicals. We found PFOS elicits an insulin-resistant phenotype adult mice, where they were not utilizing glucose readily compared controls. effect on therapeutic management interventions previously looked at. Here, we show interferes Metformin-induced decrease glucose. vast hepatic triglycerides exposure. In this thesis, was administered sub-chronic low dose (100μg/kg) daily mice fed ad libitum or placed caloric restriction (CR) for five weeks. cohort generated, observed exposure increased lipid content mature male dampened CR-induced lipids. administration did affect tolerance but interfere improvement tolerance. further associated suppression IRS-1 mRNA expression liver. As is closely tied insulin glucagon signaling production, it determined whether effects vivo due PFOSstimulated production. Using cultured mouse hepatocytes under conditions, evaluated could enhance glucagonstimulated stimulated hepatocyte production enhanced glucagon-induced Furthermore, HEPG2 cells, (25 250 μM) significantly output AiCar, which suppresses ineffective presence PFOS. These provide mechanistic explanation decreased our cohort. increases vitro models, even when challenged metformin well as, decreases utilization study suggesting glucagon-like effect. PFOA carboxylic environment. According EPA, levels widely distributed media (Houde et al., 2011; Gewertz 2013) blood general United States population. EPA known toxicant, carcinogen rodents. It detected human liver, kidney adipose tissue ranging 0.3 3.8ng/g highest concentrations (Maestri 2006). another study, obesogen mid-aged leptin altered at very concentration (Hines 2009). Potent activator peroxisomeproliferator activated receptor-alpha (Ppar-α) contributing oxidative stress activation oxidation pathways hepatocytes. Given its persistence, purpose evaluate treatment affects oxidation, synthesis, antioxidant response gene mice. Utilizing paradigm characterized by Environmental Protection Agency, treated 1.0 3.0 mg ammonium salt/kg 7 days. Adipose collected total RNA isolated. Analysis completed quantitative PCR. For most part, vehicleand PFOA-treated similar. Literature lacks data health, continue discovered. longer periods protein changes should examined.

参考文章(50)
Suryakant K. Niture, James W. Kaspar, Jun Shen, Anil K. Jaiswal, Nrf2 signaling and cell survival. Toxicology and Applied Pharmacology. ,vol. 244, pp. 37- 42 ,(2010) , 10.1016/J.TAAP.2009.06.009
M CAVE, I DEACIUC, C MENDEZ, Z SONG, S JOSHIBARVE, S BARVE, C MCCLAIN, Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition Journal of Nutritional Biochemistry. ,vol. 18, pp. 184- 195 ,(2007) , 10.1016/J.JNUTBIO.2006.12.006
K. H. Williams, N. A. Shackel, M. D. Gorrell, S. V. McLennan, S. M. Twigg, Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. Endocrine Reviews. ,vol. 34, pp. 84- 129 ,(2013) , 10.1210/ER.2012-1009
Andrew M Seacat, Peter J Thomford, Kris J Hansen, Lisa A Clemen, Sandra R Eldridge, Cliff R Elcombe, John L Butenhoff, Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats Toxicology. ,vol. 183, pp. 117- 131 ,(2003) , 10.1016/S0300-483X(02)00511-5
Marta Popovic, Roko Zaja, Karl Fent, Tvrtko Smital, Interaction of environmental contaminants with zebrafish organic anion transporting polypeptide, Oatp1d1 (Slco1d1). Toxicology and Applied Pharmacology. ,vol. 280, pp. 149- 158 ,(2014) , 10.1016/J.TAAP.2014.07.015
Adviti Naik, Aleš Belič, Ulrich M. Zanger, Damjana Rozman, Molecular Interactions between NAFLD and Xenobiotic Metabolism Frontiers in Genetics. ,vol. 4, pp. 2- 2 ,(2013) , 10.3389/FGENE.2013.00002
Valentina Gallo, Giovanni Leonardi, Bernd Genser, Maria-Jose Lopez-Espinosa, Stephanie J. Frisbee, Lee Karlsson, Alan M. Ducatman, Tony Fletcher, Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure Environmental Health Perspectives. ,vol. 120, pp. 655- 660 ,(2012) , 10.1289/EHP.1104436
Jessica W. Nelson, Elizabeth E. Hatch, Thomas F. Webster, Exposure to Polyfluoroalkyl Chemicals and Cholesterol, Body Weight, and Insulin Resistance in the General U.S. Population Environmental Health Perspectives. ,vol. 118, pp. 197- 202 ,(2009) , 10.1289/EHP.0901165
Zhiping Li, Jeanne Clark, Anna Mae Diehl, The liver in obesity and type 2 diabetes mellitus Clinics in Liver Disease. ,vol. 6, pp. 867- 877 ,(2002) , 10.1016/S1089-3261(02)00060-0
Hyung-Sub Kim, Seung Jun Kwack, Eui Sik Han, Tae Seok Kang, Seung Hee Kim, Soon Young Han, Induction of apoptosis and CYP4A1 expression in Sprague-Dawley rats exposed to low doses of perfluorooctane sulfonate. Journal of Toxicological Sciences. ,vol. 36, pp. 201- 210 ,(2011) , 10.2131/JTS.36.201